{"id":"NCT00115804","sponsor":"University of Cincinnati","briefTitle":"Safety and Efficacy of Fluoxetine in Juvenile Fibromyalgia","officialTitle":"An Open-Label Clinical Trial of Fluoxetine Treatment of Juvenile Primary Fibromyalgia Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-06","primaryCompletion":"2011-02","completion":"2011-02","firstPosted":"2005-06-27","resultsPosted":"2013-02-15","lastUpdate":"2017-02-10"},"enrollment":6,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Juvenile Primary Fibromyalgia Syndrome (JPFS)","Fibromyalgia"],"interventions":[{"type":"DRUG","name":"Fluoxetine","otherNames":["Prozac"]}],"arms":[{"label":"Fluoxetine","type":"EXPERIMENTAL"}],"summary":"The purpose of this research is to conduct an open, pilot trial to assess the efficacy and safety of fluoxetine in the treatment of Juvenile Primary Fibromyalgia Syndrome (JPFS).","primaryOutcome":{"measure":"Average Pain Severity Score","timeFrame":"Daily on average in the past week.","effectByArm":[{"arm":"Fluoxetine","deltaMin":62,"sd":11.9}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":6},"commonTop":["Headache"]}}